ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 752385 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 752385; 2) Community: the network communities that were significantly associated with the response to NSC 752385; 3) Molecule: the relationships between components within communities and NSC 752385; 4) MDR: the compounds that were significantly associated with the NSC 752385.

NSC Compound Enrichment Correlation
NSC 713326 Null 0.0176693828663438 0.35366482
NSC 732336 [6-(4-bromophenyl)imidazo[2,1-b]thiazol-3-yl]acetic acid 2-hydroxy-5-bromobenzylidenehydrazide 0.0176693828663438 -0.03583583
NSC 736116 6-(3-Amonopropyl)-5,6-dihydro-9-methyl-3-nitro-5,11-dioxo-11 H-indeno[1,2-c]isoquinoline Hydrochloride 0.0176693828663438 0.27438943
NSC 755119 Null 0.0210605194802431 0.46399105
NSC 761817 (Z)-5-methoxy-3-((1-(3,4,5-trimethoxyphenyl)-9H-pyrido[3,4-b]indol-3-yl)methylene)indolin-2-one 0.0210605194802431 0.36167272
NSC 762921 Null 0.0210605194802431 0.071697105
NSC 764090 BMS-777607 0.0210605194802431 0.3522905
NSC 143019 METHANEDIAMINE, N,N'-BIS(1,3,4-THIADIAZOL-2-YL)- 0.0210605194802434 0.088277769
NSC 266047 1,2-Cyclohexanediamine, platinum complex, (1R-trans)- (9CI) 0.0210605194802434 0.31558662
NSC 373355 Saframycin R 0.0210605194802434 0.12236394
Total:42  Current:15    [First] [Prev] [Next] [Last]